Leukemia B-cell
📧 Sign up to get email alerts when something new happens for Leukemia B-cell.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Safety and Efficacy of CD19-Targeted CAR-T Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma [Phase 1, Phase 2]
A phase 1/2 clinical trial update evaluating a CD19-targeted CAR-T therapy for relapsed/refractory CD19-positive B cell leukemia and lymphom…
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: CD19+Targeted CAR-T Cell Therapy for Relapsed/Refractory CD19+ B Cell Leukemia and Lymphoma [Phase 1, Phase 2]
Phase 1/2 clinical trial update for a CD19-targeted CAR-T cell therapy in relapsed/refractory CD19+ B-cell leukemias and lymphomas.
-
CLINICAL_TRIALS trial_result · 2022-07-01Clinical Trial Update: Precision Diagnosis Directing HDACi and TKI Target Therapy for Adult Ph-like ALL [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial is exploring precision diagnosis directing HDAC inhibitors and tyrosine kinase inhibitors for adult Philade…
-
CLINICAL_TRIALS trial_result · 2019-04-03Clinical Trial Update: Re-Induction Therapy for Relapsed Pediatric T-Cell Acute Lymphoblastic Leukemia or Lymphoma [Phase 2]
Phase 2 trial update on re-induction therapy for relapsed pediatric T-cell acute lymphoblastic leukemia or lymphoma; study terminated with p…